|
BEAM
|
Beam Therapeutics Inc.
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
US
|
NYSE
|
|
CRSP
|
CRISPR Therapeutics AG
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
US
|
NASDAQ
|
|
IMV
|
IMV Inc.
|
US
|
NASDAQ
|
|
MNOV
|
MediciNova, Inc.
|
US
|
NASDAQ
|
|
MTEM
|
Molecular Templates, Inc.
|
US
|
NASDAQ
|
|
PEPG
|
PepGen Inc.
|
US
|
NASDAQ
|
|
SRRK
|
Scholar Rock Holding Corporation
|
US
|
NASDAQ
|
|
VCNX
|
Vaccinex, Inc.
|
US
|
NASDAQ
|
|
VRDN
|
Viridian Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
|
LVCLF
|
Living Cell Technologies Ltd
|
US
|
OTC
|
|
LVCLY
|
Living Cell Tech ADR
|
US
|
OTC
|
|
PTCHF
|
PureTech Health plc
|
US
|
OTC
|
|
RLFTD
|
Relief Therapeutics Hldg Ag
|
US
|
OTC
|
|
RLFTF
|
Relief Therapeutics Holding AG
|
US
|
OTC
|